Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.

作者: Laurent Créancier , Isabelle Vandenberghe , Bruno Gomes , Caroline Dejean , Jean-Christophe Blanchet

DOI: 10.1016/J.CANLET.2015.05.013

关键词:

摘要: Chromosomal rearrangements of the NTRK1 gene, which encodes high affinity nerve growth factor receptor (tropomyosin related kinase, TRKA), have been observed in several epithelial cancers, such as colon cancer, papillary thyroid carcinoma or non small cell lung cancer. The various fusions described so far lead to constitutive activation TRKA kinase activity and are oncogenic. We further investigated here existence frequency gene colorectal Using immunohistochemistry quantitative reverse transcriptase PCR, we analyzed a series human cancers. identified two positive cases over 408, with chromosomal rearrangements. One these is TPM3-NTRK1 fusion already while second one TPR-NTRK1 never this type These findings confirm that translocations recurring events although occurring at low (around 0.5%).

参考文章(18)
I. Bongarzone, C. Lanzi, A. Greco, S. Pagliardini, G. Della Porta, M. A. Pierotti, TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene. ,vol. 7, pp. 237- 242 ,(1992)
Doron Lipson, Philip J Stephens, Vince A Miller, Marileila Varella-Garcia, Pasi A Jänne, Robert C Doebele, Aria Vaishnavi, Marzia Capelletti, Anh T Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D Davies, Dara L Aisner, Amanda B Pilling, Eamon M Berge, Jhingook Kim, Hidefumi Sasaki, Seung-il Park, Gregory Kryukov, Levi A Garraway, Peter S Hammerman, Julia Haas, Steven W Andrews, Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nature Medicine. ,vol. 19, pp. 1469- 1472 ,(2013) , 10.1038/NM.3352
Anna Kruczynski, Georges Delsol, Camille Laurent, Pierre Brousset, Laurence Lamant, Anaplastic lymphoma kinase as a therapeutic target. Expert Opinion on Therapeutic Targets. ,vol. 16, pp. 1127- 1138 ,(2012) , 10.1517/14728222.2012.719498
Kristina Brennan, Rajmohan Murali, Maria Garrido, Vincent A. Miller, Jeffrey S. Ross, Michael F. Berger, Alyssa Sparatta, Gabriele Palmedo, Lorenzo Cerroni, Klaus J. Busam, Heinz Kutzner, Maureen T. Cronin, Philip J. Stephens, Boris C. Bastian, Thomas Wiesner, Jie He, Roman Yelensky, Rosaura Esteve-Puig, Thomas Botton, Iwei Yeh, Doron Lipson, Geoff Otto, Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nature Communications. ,vol. 5, pp. 3116- 3116 ,(2014) , 10.1038/NCOMMS4116
Elena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, Cristina De Ponti, Alessio Somaschini, Rosaria Cammarota, Nadia Amboldi, Laura Raddrizzani, Andrea Milani, Paola Magnaghi, Dario Ballinari, Daniele Casero, Fabio Gasparri, Patrizia Banfi, Nilla Avanzi, Maria B. Saccardo, Rachele Alzani, Tiziano Bandiera, Eduard Felder, Daniele Donati, Enrico Pesenti, Andrea Sartore-Bianchi, Marcello Gambacorta, Marco A. Pierotti, Salvatore Siena, Silvio Veronese, Arturo Galvani, Antonella Isacchi, The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition Molecular Oncology. ,vol. 8, pp. 1495- 1507 ,(2014) , 10.1016/J.MOLONC.2014.06.001
Jinkuk Kim, Yeri Lee, Hee-Jin Cho, Young-Eun Lee, Jaeyeol An, Gye-Hyun Cho, Young-Hyeh Ko, Kyeung Min Joo, Do-Hyun Nam, NTRK1 Fusion in Glioblastoma Multiforme PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0091940
Robert C. Doebele, D. Ross Camidge, Targeting ALK, ROS1, and BRAF Kinases Journal of Thoracic Oncology. ,vol. 7, pp. S375- S376 ,(2012) , 10.1097/JTO.0B013E31826DF05E
Andrea Marin Marques, Alice Turner, Ramon Andrade De Mello, Personalizing medicine for metastatic colorectal cancer: Current developments World Journal of Gastroenterology. ,vol. 20, pp. 10425- 10431 ,(2014) , 10.3748/WJG.V20.I30.10425
Nicolas Stransky, Ethan Cerami, Stefanie Schalm, Joseph L. Kim, Christoph Lengauer, The landscape of kinase fusions in cancer. Nature Communications. ,vol. 5, pp. 4846- 4846 ,(2014) , 10.1038/NCOMMS5846